1. Home
  2. HRMY vs KALU Comparison

HRMY vs KALU Comparison

Compare HRMY & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$35.34

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$166.00

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
KALU
Founded
2017
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
HRMY
KALU
Price
$35.34
$166.00
Analyst Decision
Buy
Hold
Analyst Count
9
3
Target Price
$44.11
$147.33
AVG Volume (30 Days)
910.7K
284.8K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
1.78%
EPS Growth
7.97
135.89
EPS
0.55
9.43
Revenue
$868,453,000.00
$1,585,900,000.00
Revenue This Year
$19.75
$13.37
Revenue Next Year
$12.88
$2.62
P/E Ratio
$65.09
$48.68
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$71.44
52 Week High
$40.87
$195.96

Technical Indicators

Market Signals
Indicator
HRMY
KALU
Relative Strength Index (RSI) 51.31 45.97
Support Level $35.05 $157.54
Resistance Level $35.47 $195.20
Average True Range (ATR) 1.59 7.46
MACD -0.20 0.59
Stochastic Oscillator 46.08 29.31

Price Performance

Historical Comparison
HRMY
KALU

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

Share on Social Networks: